Consistently, cancer patients present lower levels of HDL cholesterol compared to healthy subjects, suggesting that cancer cells exploit HDL cholesterol from peripheral tissues to sustain their malignant phenotype by picking it up in a SRB1-mediated fashion (36). The gene discussed is SCARB1; the disease is cancer.